Conclusion:
While this case was treated successfully without complications, it
serves as an addition to the literature describing the clinical features
of children who developed NS in the setting of a COVID-19. This will
help medical providers in the management and future prognostication of
the disease. This case additionally can serve as a basis for case
control studies assessing whether COVID-19 infection (exposure) is a
risk factor for the development of new onset or relapse of nephrotic
syndrome (outcome) in children. To date, this is only the fourth
pediatric case report on a new onset NS associated with a COVID-19
infection.